Kenya only needs 100 million to try and eliminate malaria by 2017. This was announced at the same conference this past November where Artepharm discussed their very successful Comoros project. Kenya is also one of the few countries that Artequick is number one in private sales and is obviously very aware of the companies achievements. If the second Comoros project is anywhere near as successful as the first this stock could really take off. imo
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.